KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Realty Trust (HR) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Healthcare Realty Trust (HR) over the last 17 years, with Q4 2025 value amounting to -$17.3 million.

  • Healthcare Realty Trust's Net Cash Flow fell 14051.97% to -$17.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$42.7 million, marking a year-over-year decrease of 19890.55%. This contributed to the annual value of -$42.7 million for FY2025, which is 19890.55% down from last year.
  • Latest data reveals that Healthcare Realty Trust reported Net Cash Flow of -$17.3 million as of Q4 2025, which was down 14051.97% from $17.8 million recorded in Q3 2025.
  • Healthcare Realty Trust's 5-year Net Cash Flow high stood at $89.1 million for Q2 2021, and its period low was -$85.7 million during Q1 2021.
  • Moreover, its 5-year median value for Net Cash Flow was $204500.0 (2024), whereas its average is $543450.0.
  • In the last 5 years, Healthcare Realty Trust's Net Cash Flow soared by 404713.87% in 2024 and then plummeted by 923192.39% in 2025.
  • Quarter analysis of 5 years shows Healthcare Realty Trust's Net Cash Flow stood at -$2.8 million in 2021, then soared by 219.58% to $3.4 million in 2022, then plummeted by 69.48% to $1.0 million in 2023, then surged by 4047.14% to $42.8 million in 2024, then tumbled by 140.52% to -$17.3 million in 2025.
  • Its Net Cash Flow stands at -$17.3 million for Q4 2025, versus $17.8 million for Q3 2025 and -$64000.0 for Q2 2025.